These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 33620750

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modelling the contribution of incarceration and public health oriented drug law reform to HCV transmission and elimination among PWID in Tijuana, Mexico.
    Saldana CDR, Beletsky L, Borquez A, Kiene SM, Marquez LK, Strathdee SA, Zúñiga ML, Cepeda J, Martin NK.
    Int J Drug Policy; 2022 Dec; 110():103878. PubMed ID: 36242829
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.
    Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Mabileau G, Dhersin JS, Yazdanpanah Y.
    J Viral Hepat; 2018 Oct; 25(10):1197-1207. PubMed ID: 29660211
    [Abstract] [Full Text] [Related]

  • 6. Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis.
    Rivera Saldana CD, Abramovitz D, Beletsky L, Borquez A, Kiene S, Marquez LK, Patton T, Strathdee S, Zúñiga ML, Martin NK, Cepeda J.
    Addiction; 2023 Sep; 118(9):1763-1774. PubMed ID: 37039246
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness model.
    Scott N, Mohamed Z, Rwegasha J, Mbwambo J, Lemoine M, Hellard M.
    Int J Drug Policy; 2021 Feb; 88():102634. PubMed ID: 31882272
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.
    Barbosa C, Fraser H, Hoerger TJ, Leib A, Havens JR, Young A, Kral A, Page K, Evans J, Zibbell J, Hariri S, Vellozzi C, Nerlander L, Ward JW, Vickerman P.
    Addiction; 2019 Dec; 114(12):2267-2278. PubMed ID: 31307116
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Echevarria D, Gutfraind A, Boodram B, Layden J, Ozik J, Page K, Cotler SJ, Major M, Dahari H.
    Vaccine; 2019 May 01; 37(19):2608-2616. PubMed ID: 30962092
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use Population.
    Stevens ER, Nucifora KA, Hagan H, Jordan AE, Uyei J, Khan B, Dombrowski K, des Jarlais D, Braithwaite RS.
    Clin Infect Dis; 2020 Jun 10; 70(12):2652-2662. PubMed ID: 31400755
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?
    Martin NK, Boerekamps A, Hill AM, Rijnders BJA.
    J Int AIDS Soc; 2018 Apr 10; 21 Suppl 2(Suppl Suppl 2):e25062. PubMed ID: 29633560
    [Abstract] [Full Text] [Related]

  • 18. Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States.
    Zelenev A, Li J, Shea P, Hecht R, Altice FL.
    Clin Infect Dis; 2021 Mar 01; 72(5):755-763. PubMed ID: 32060534
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?
    Lanièce Delaunay C, Godin A, Kronfli N, Panagiotoglou D, Cox J, Alary M, Klein MB, Maheu-Giroux M.
    Int J Drug Policy; 2021 Oct 01; 96():103343. PubMed ID: 34215459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.